GlaxoSmithKline (GSK) has appointed Emma Walmsley as new CEO
Global pharma and healthcare firm GSK today announced an appointment of Emma Walmsley as CEO-designate of the company. Walmsley, currently CEO of GSK’s Consumer Healthcare division, will succeed Andrew Witty when he retires on March 21, 2017, said a statement. She will join the GSK board from January 1 next year, it added. Prior to…